Pathology Ventures Names Dominic Stockey Executive Vice President

Former healthcare investment banker to lead sponsor and industry partnerships; available for meetings at CAP26 in Las Vegas, Oct. 3–6

SHREVEPORT, La., Sept. 29, 2026 /PRNewswire/ -- Pathology Ventures, LLC (PVL), a physician-founded network representing more than 500 pathologists, has named Dominic Stockey executive vice president. Stockey will lead PVL's partnerships with pharmaceutical, diagnostic and research sponsors as the company expands its biomarker standards and industry programs across pathology practices.

Stockey oversees business operations, strategic partnerships and enterprise development, including sponsor and partner relationships, commercialization and contracting, and program execution. He joins PVL after seven years in investment banking, where he was a Vice President and worked on more than 15 closed transactions across diagnostics, life sciences and healthcare, including mergers and acquisitions, capital formation and industry partnerships.

"Pathologists are central to getting patients the right biomarker testing, and gaps in that testing have real consequences for treatment," said Sam Caughron, MD, President. "Our physicians have done the clinical work of defining what good testing looks like. Dominic brings the business leadership to turn that work into programs industry partners can invest in, while making sure our member practices stay independent."

PVL gives pathology practices a way to collaborate on biomarker programs and industry projects without giving up ownership of their groups. The company was founded in 2025 by Samuel K. Caughron, MD, Eric F. Glassy, MD, and Vivek K. Khare, MD.

"Pharmaceutical and diagnostic companies want to work with pathology practices, but they need a partner that can bring those practices together around consistent standards and deliver programs at scale," said Stockey. "PVL's physicians have built that foundation. My job is to build partnerships around it that work for sponsors, for our member practices and, ultimately, for patients."

Stockey and PVL leadership will attend CAP26, the College of American Pathologists annual meeting, at the Wynn Las Vegas, Oct. 3–6. To schedule a meeting, contact Dominic at [email protected].

About Pathology Ventures, LLC

Pathology Ventures, LLC is a physician-founded company based in Shreveport, Louisiana. It connects pathology practices with pharmaceutical, diagnostic, technology and research organizations on biomarker standardization, implementation, quality improvement, digital pathology and data programs. Learn more at www.pathologyventures.com.

Media Contact:
Dominic Stockey
Executive Vice President
Pathology Ventures, LLC
[email protected] 

SOURCE Pathology Ventures, LLC